Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125392091 | 12539209 | 1 | I | 20160415 | 20160422 | 20160708 | 20160708 | PER | US-ASTRAZENECA-2016SE45713 | ASTRAZENECA | 28875.00 | DY | F | Y | 88.50000 | KG | 20160708 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125392091 | 12539209 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 120 | MG | Y | U | 21366 | 40 | MG | TABLET | QD | |||
| 125392091 | 12539209 | 2 | SS | BRILINTA | TICAGRELOR | 1 | Oral | 540 | MG | 0 | 90 | MG | TABLET | BID | |||||
| 125392091 | 12539209 | 3 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | |||||||||||
| 125392091 | 12539209 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 125392091 | 12539209 | 5 | C | METOPROLOL TARTATE | METOPROLOL TARTRATE | 1 | Oral | 0 | .5 | DF | BID | ||||||||
| 125392091 | 12539209 | 6 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 125392091 | 12539209 | 7 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG DAILY AS NEEDED | 0 | ||||||||||
| 125392091 | 12539209 | 8 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 300 | MG | QD | ||||||||
| 125392091 | 12539209 | 9 | C | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | 0 | 50 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125392091 | 12539209 | 1 | Anticoagulant therapy |
| 125392091 | 12539209 | 7 | Fluid retention |
| 125392091 | 12539209 | 8 | Diuretic therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125392091 | 12539209 | Abdominal pain upper | |
| 125392091 | 12539209 | Hypersensitivity | |
| 125392091 | 12539209 | Off label use | |
| 125392091 | 12539209 | Pain in extremity | |
| 125392091 | 12539209 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125392091 | 12539209 | 1 | 20160413 | 20160416 | 0 | |
| 125392091 | 12539209 | 2 | 20160413 | 0 | ||
| 125392091 | 12539209 | 3 | 20160421 | 0 | ||
| 125392091 | 12539209 | 5 | 20160413 | 0 |